Applications of DL-O-Phosphoserine in Industrial Manufacturing

DL-O-Phosphoserine serves as a critical intermediate and additive in select industrial sectors, where its unique phosphorylated serine structure supports both biosynthetic pathways and functional molecule design. As a direct manufacturer, we supply this material tailored for high-specification downstream applications, backed by technical expertise in purity, compliance, and process integration. Below, we detail principal, established industry uses aligning with regulatory standards and market production flows.

1. Pharmaceutical Peptide Synthesis

DL-O-Phosphoserine plays a critical role as a protected amino acid residue in solid-phase peptide synthesis, especially when constructing phosphorylated peptide APIs and peptide research tools for pharmaceutical R&D. Manufacturers incorporate this raw material to create site-specific phosphorylation motifs, indispensable for kinase inhibitor screening and advanced diagnostic reagent development, where the strictest international pharmacopeial standards govern material selection and traceability from initial resin loading to final deprotection and purification.

Industry compliance standards

• ICH Q7 GMP for Active Pharmaceutical Ingredients
• USP/NF and EP monographs on amino acid derivatives
• ISO 9001:2015 for quality management
• FDA 21 CFR Part 210/211 for drug substance manufacturing

Typical usage ratio

• Solid-phase synthesis loading rates: 0.5–2.0 mmol/g (resin substitution)
• Peptide chain composition: up to 1:20 molar ratio to standard L-serine, based on sequence design
• Adjusted per target peptide length and phospho-serine frequency within sequence

Downstream process integration

• Direct coupling during growing peptide chain on resin, following standard Fmoc/t-Boc protocols
• Integrated into purified peptide after global deprotection and cleavage
• Controlled-use at protected amino acid charge-in step to avoid phosphorylation migration

Final product types

• Phosphorylated peptide APIs for oncology and metabolic disorder trials
• Custom peptide research reagents for kinase assay kits
• Diagnostic peptide standards for immunoassay calibration

2. Specialty Biochemical Reagent Manufacturing

DL-O-Phosphoserine finds established use in the manufacturing of specialty biochemical reagents for cell signaling and protein phosphorylation studies. Research reagent producers rely on this raw material to formulate buffers and substrates for in vitro kinase activity studies and structural biology investigations, necessitating strict analytical purity and batch traceability. The supply chain aligns with international laboratory chemical requirements, with transparent certificate of analysis and material origin records as required by top-tier global institutions.

Industry compliance standards

• ISO 13485:2016 for medical device reagents where relevant
• REACH Registration (EC 1907/2006) for laboratory chemicals
• OECD Good Laboratory Practice (GLP) Principles
• Applicable GHS/CLP hazard labeling for laboratory distribution

Typical usage ratio

• Buffer and substrate formulations: 0.1–5 mM working concentration
• Stock solutions: up to 100 mM in deionized water, filtered as needed
• Final use concentration varies with cell or enzyme assay protocol

Downstream process integration

• Direct dissolution in analytical-grade solvents during final formulation
• Aliquoting and sterile filtration prior to vials or bulk packaging
• Incorporated as component in commercial protein modification kits

Final product types

• Kinase substrate buffers for research and screening
• Phosphorylation site mapping reagent kits
• High-purity amino acid standards for HPLC and mass spectrometry QC

3. Biomedical Culture Media Enrichment

DL-O-Phosphoserine supports advanced cell and microbial culture applications, particularly in the pharmaceutical and biotechnology sectors where researchers investigate serine metabolism and post-translational protein modifications. Media manufacturers add this material to specialized, serum-free, or chemically defined media formulations to support phosphorylation pathway studies, with strict controls to ensure identity, purity, and consistency for regulated laboratory and clinical settings.

Industry compliance standards

• USP Chapter <1043> Ancillary Materials for Cell, Gene, and Tissue-Engineered Products
• ISO 9001:2015 for documented traceability
• ISO 13485 where medical-grade cell media is produced
• Pharmaceutical grade raw material specifications (in-house QC validated)

Typical usage ratio

• Culture media additive: 10–200 mg/L depending on intended study (hyperphosphorylation modeling may require higher concentrations within validated range)
• Fine adjustment based on target cell line sensitivity and downstream assay requirements

Downstream process integration

• Dissolved into basal media during hydration or pre-autoclave blending
• Sterile-filtered addition for post-autoclave supplementation
• Verified homogeneity by amino acid analyzer prior to packaging

Final product types

• Chemically defined cell culture media for bioprocessing R&D
• Phospho-serine enriched test kits for metabolic research
• Supplemented microbial or mammalian tissue culture broths

4. Bioconjugate and Analytical Reference Material Manufacture

Bioconjugation and analytical laboratories use DL-O-Phosphoserine as a standard for phosphorylation site calibration and as a building block in synthetic bioconjugate reagents. Its defined phosphoryl group enables standardization in LC/MS and NMR investigation of protein modifications, as well as in producing conjugates for antibody production against phospho-proteins. High transparency of documentation and non-animal sourced manufacturing processes are mandatory for reference material suppliers.

Industry compliance standards

• ISO/IEC 17025 accreditation for reference material production
• NIST Traceability protocols for certified reference materials (CRMs)
• OECD Good Manufacturing Practice where applicable
• EU Regulation (EC) No 765/2008 for analytical products

Typical usage ratio

• Analytical calibration: 1–10 μg/mL in standard solution preparation
• Bioconjugation: stoichiometric addition based on molar ratios for antibody binding epitope design (commonly 1:1 to target protein or peptide fragment)
• Increased dose where multiple phosphorylations are modeled, based on analytical method sensitivity

Downstream process integration

• Dissolved and derivatized for direct use in calibration mix preparation
• Mixed into bioconjugate formulation at conjugation reaction stage
• Integral to QC batches for method validation and instrument calibration

Final product types

• Certified reference standards for LC/MS and capillary electrophoresis
• Synthetic bioconjugates for immunogen preparation
• Peptide-phospho standards used in biopharmaceutical assay development